Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Vertex Pharma Promising, Volatile - Analyst Blog
Oct 28, 2008 02:17 PM
- Complete Rout
Oct 15, 2008 10:48 PM
- Sharp Sell-Off Ahead Of House Vote
Oct 02, 2008 08:45 PM
- Market Rallies After Opening Down-Gap
Sep 27, 2008 11:33 AM
- Indices Bounce Back With A Positive Session, Despite Afternoon Pullback
Sep 25, 2008 06:05 PM
- Analyst Comments: Hess Corp, Mylan, AvalonBay, Abbott Labs, Trimble, NCR Corp, Vertex Pharma, American Tower, Sony, Washington Federal, Boston Properties, Johnson & Johnson, Matsushita, Deckers, Mechel Steel, Kroger
Sep 18, 2008 01:37 PM
- Periodicals Wrap-Up for Monday, August 18
Aug 18, 2008 09:50 AM
- Institutional Money Flocking in Biotech
Aug 15, 2008 01:23 PM
- Periodicals Wrap-Up for Wednesday, August 6th
Aug 06, 2008 09:59 AM
- Ahead Of The Fed
Aug 04, 2008 10:48 AM
- Vertex Pharmaceuticals Announces Webcast of its Presentation at Two Investor Conferences
Nov 26, 2008 09:17 AM
- Vertex Pharmaceuticals Announces Webcast of its Presentation at Two Investor Conferences
Nov 14, 2008 09:21 AM
- Vertex Pharmaceuticals Announces Webcast of its Presentation at Two Investor Conferences
Nov 06, 2008 04:48 PM
- New Clinical Data Support Broad Profile for Telaprevir in Patients with Genotype 1 Hepatitis C Virus (HCV) Infection
Nov 01, 2008 11:01 AM
- Zacks Analyst Blog Highlights: Cache, Inc., WPP Group Plc., Companhia Vale Do Rio Doce, Vertex Pharmaceuticals Inc. And Johnson & Johnson
Oct 29, 2008 01:13 AM
- Vertex Pharmaceuticals Highlights Progress with Hepatitis C and Cystic Fibrosis Programs and Reports Third Quarter 2008 Results
Oct 27, 2008 04:06 PM
- Vertex Announces Positive 28-Day Results for VX-770, an Oral Investigational Agent That Targets a Defective Protein Responsible for Cystic Fibrosis
Oct 20, 2008 07:34 AM
- Vertex Pharmaceuticals Announces the Date of its Third Quarter 2008 Financial Results Conference Call and Webcast
Oct 16, 2008 05:40 PM
- Vertex Pharmaceuticals Announces Webcast of its Presentation at the JMP Securities Healthcare Focus Conference
Oct 01, 2008 04:16 PM
- Vertex Pharmaceuticals Announces Correction to Abstract Data Published in October 2008 Supplement to Hepatology
Sep 24, 2008 10:02 AM
- Form 4 BOGER JOSHUA S For: Nov 26 (10K)
Dec 01, 2008 03:41 PM
- Form 4 BOGER JOSHUA S For: Nov 19 (10K)
Nov 20, 2008 04:02 PM
- Form 4 VERTEX PHARMACEUTICALS For: Nov 18 Filed by: Silva Paul M (10K)
Nov 19, 2008 04:56 PM
- Form 4 VERTEX PHARMACEUTICALS For: Nov 18 Filed by: Graves Kurt (10K)
Nov 19, 2008 04:48 PM
- Form 4 VERTEX PHARMACEUTICALS For: Nov 18 Filed by: BOGER KENNETH S (10K)
Nov 19, 2008 01:00 PM
- Form 4 VERTEX PHARMACEUTICALS For: Nov 17 Filed by: MUELLER PETER (10K)
Nov 19, 2008 01:00 PM
- Form 4 VERTEX PHARMACEUTICALS For: Nov 12 Filed by: BOGER JOSHUA S (10K)
Nov 13, 2008 02:53 PM
- Form 4 VERTEX PHARMACEUTICALS For: Nov 05 Filed by: BOGER JOSHUA S (10K)
Nov 06, 2008 02:45 PM
- Form 4 BOGER JOSHUA S For: Oct 29 (10K)
Oct 30, 2008 03:04 PM
- Form 4 BOGER JOSHUA S For: Oct 22 (10K)
Oct 23, 2008 03:40 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
VRTX
|
Compare to S&P
|
| YTD |
5.85 %
|
73.43 %
|
| 4 Weeks |
-6.18 %
|
1.41 %
|
| 12 Weeks |
-6.29 %
|
29.90 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -43.08 %
|
|
EPS Growth in Last Year: -13.41 %
|
|
Sales Growth in Last Quarter: -54.46 %
|
|
Sales Growth in Last Quarter: -22.93 %
|
|
|
